Drug or treatment

Girentuximab clinical trials

As of November 12, 2026, Find a Trial lists 4 clinical trials of Girentuximab that are recruiting, at sites in 4 countries (most in France (1), China (1), United States (1)). By phase: Phase 3 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
177Lu-TLX250 for advanced relapsed or recurrent clear-cell kidney cancer Phase 3 Sydney, New South Wales and 4 other locations Recruiting Sep 29, 2025
89Zr-TLX250 for imaging clear cell kidney cancer Phase 3 Beijing and 7 other locations Recruiting Dec 27, 2024
PET/CT with zirconium‑labelled girentuximab to image CAIX in liver and gastro‑entero‑pancreatic neuroendocrine tumors — Nantes and 1 other locations Recruiting Dec 16, 2024
Combination treatment for advanced clear cell kidney cancer Phase 1/2 Houston, Texas Recruiting Dec 23, 2022

All recruiting trials (4)

Quick answers

How many clinical trials of Girentuximab are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in France (1 trial), China (1 trial), United States (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.